Americas Sleep Apnea Market Forecast to 2030 - Regional Analysis By Type (Diagnostic Devices and Therapeutic Devices) and End User (Hospitals, Homecare Settings, and Others)

Description

List of Tables

The Americas sleep apnea market is expected to grow from $ 2,454.20 million in 2022 and is expected to reach to a value of US$ 4,103.24 million by 2030, it is anticipated to record a CAGR of 6.6% from 2022 to 2030. The driving factors include increasing prevalence of sleep apnea and growing demand for sleep apnea diagnostic devices and therapeutic solutions. However, low awareness of sleep apnea is hampering the Americas sleep apnea market growth.

Many market players and research institutes operating in the Americas sleep apnea market are developing advanced products to expand their product portfolios and increase their market shares. They invest significant amounts in R&D to develop advanced products. A few of the recent developments related to sleep apnea are mentioned below:

In September 2021, Cadwell is proud to announce the release of the E3 cart for the Easy III PSG and EEG systems into the USA Market. The E3 Cart is designed to be an ergonomic, mobile workstation with optimal shelf and storage space for accessories commonly used in a sleep lab, such as CPAP equipment, Transcutaneous CO2 monitors and a EtCO2 monitors.

In September 2021, Philips anticipates rework to commence in the course of September 2021. In addition to the rework, the company has already started replacing certain affected first-generation DreamStation CPAP devices in the US with DreamStation 2 CPAP devices.

Thus, such development are likely to introduce new trends in the Americas sleep apnea market during the forecast period.

Constant technological advancements and awareness regarding sleep apnea are boosting the adoption of various medical devices, such as PSG and home sleep testing. Many industry players are focusing on innovative product strategies to meet the growing demand for sleep apnea diagnostic devices. For instance, in August 2021, ResMed successfully launched "AirSense 11," the first available in the US. It is the company's next-generation positive airway pressure device designed to assist people suffering from sleep apnea. In August 2020, Nihon Koden Corporation announced the launch of Polysmith 12 polysomnography software. The Polysmith software includes more than 40 market-driven features that offer sleep specialists to improve workflow, analysis, and outcomes of the medical device. The new product also offers a cost-effective design with a broad range of features, such as the enhancement of scheduling, prioritization, and email notification capabilities for enhanced workflow, improved status tracking to organize patients based on priority and status, and the ability to track patient progress to improve clinical outcomes. In September 2021, Sommetrics, a pioneer in manufacturing products and services to improve sleep health, announced the launch of a pivotal clinical trial for the "aerSleep II device" for the treatment of OSA. The company termed the clinical trial as "SUPRA study" (i.e., Study Using Negative Pressure to Reduce Sleep Apnea). The trial aims to evaluate the treatment benefits and safety of applying a mild external vacuum over the upper way airway with the aerSleep II device. Thus, such innovative product launches and clinical trials are projected to offer lucrative opportunities to the market players during the forecast period.

Type-Based Insights

Based on type, the global Americas sleep apnea market is segmented into diagnostic devices and therapeutic devices. Diagnostic devices is further sub-segmented as polysomnography devices (PSG), home sleep testing devices, pulse oximeters, actigraphy devices, and others. Therapeutic devices is further sub-segmented as PAP, sleep masks, oral appliances, and others. The therapeutics segment held the largest market share in 2022 and diagnostic devices is anticipated to register the highest CAGR of 7.4% during the forecast period (2022-2030).

End-User-Based Insights

Based on end-user, the Americas sleep apnea market, is segmented into hospitals, homecare settings, and others. The hospitals segment held the largest share of the market in 2022 and homecare settings is expected to grow at the highest CAGR during the forecast period.

A few of the major primary and secondary sources referred to while preparing the report on the Americas sleep apnea market are the World Health Organization (WHO), the US Census Bureau, and the US National Library of Medicine, among others.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Americas sleep apnea market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global Americas sleep apnea market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Product Code: TIPRE00030024

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Americas Sleep Apnea Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Americas Sleep Apnea Market - Market Landscape

4.1 Overview
- 4.1.1 Americas PEST Analysis

5. Sleep Apnea Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Sleep Apnea
- 5.1.2 Growing Demand for Sleep Apnea Diagnostic Devices and Therapeutic Solutions
5.2 Market Restraints
- 5.2.1 Low Awareness of Sleep Apnea
5.3 Market Opportunities
- 5.3.1 Innovative Product Launches and Clinical Trials
5.4 Future Trends
- 5.4.1 Technological Developments
5.5 Impact Analysis

6. Americas Sleep Apnea Market - Regional Analysis

6.1 Americas Sleep Apnea Market Revenue Forecast and Analysis

7. Americas Sleep Apnea Market - Revenue and Forecast to 2030 - by Type

7.1 Overview
7.2 Americas Sleep Apnea Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Diagnostic Devices
- 7.3.1 Overview
- 7.3.2 Diagnostic Devices: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.3 Polysomnography Devices (PSG)
  - 7.3.3.1 Overview
  - 7.3.3.2 Polysomnography Devices (PSG): Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.4 Home Sleep Testing Devices
  - 7.3.4.1 Overview
  - 7.3.4.2 Home Sleep Testing Devices: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.5 Pulse Oximeters
  - 7.3.5.1 Overview
  - 7.3.5.2 Pulse Oximeters: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.6 Actigraphy Devices
  - 7.3.6.1 Overview
- 7.3.7 Actigraphy Devices: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.8 Others
  - 7.3.8.1 Overview
- 7.3.9 Others: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Therapeutic Devices
- 7.4.1 Overview
- 7.4.2 Therapeutic Devices: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.3 PAP
  - 7.4.3.1 Overview
  - 7.4.3.2 PAP: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.4.3.3 CPAP
    - 7.4.3.3.1 Overview
    - 7.4.3.3.2 CPAP: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.4.3.4 APAP
    - 7.4.3.4.1 Overview
    - 7.4.3.4.2 APAP: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.4.3.5 Bi-PAP
    - 7.4.3.5.1 Overview
    - 7.4.3.5.2 Bi-PAP: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.4 Sleep Masks
  - 7.4.4.1 Overview
  - 7.4.4.2 Sleep Masks: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.5 Oral Appliances
  - 7.4.5.1 Overview
  - 7.4.5.2 Oral Appliances: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.6 Others
  - 7.4.6.1 Overview
  - 7.4.6.2 Others: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)

8. Americas Sleep Apnea Market Analysis and Forecasts to 2028 - by End User

8.1 Overview
8.2 Americas Sleep Apnea Market, by End User 2022 & 2030 (%)
8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Hospitals: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Homecare Settings
- 8.4.1 Overview
- 8.4.2 Homecare Settings: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Americas Sleep Apnea Market - Revenue and Forecast to 2030 (US$ Million)

9. Americas Sleep Apnea Market - Revenue and Forecast to 2030 - Geographic Analysis

9.1 Americas Sleep Apnea Market, Revenue and Forecast to 2030
- 9.1.1 Overview
- 9.1.2 Americas Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.2.1 Americas Sleep Apnea Market, by Type
  - 9.1.2.2 Americas Sleep Apnea Market, by Diagnostic Devices
  - 9.1.2.3 Americas Sleep Apnea Market, by Therapeutic Devices
    - 9.1.2.3.1 Americas Sleep Apnea Market, by PAP
  - 9.1.2.4 Americas Sleep Apnea Market, by End User
  - 9.1.2.5 Americas Sleep Apnea Market by Country
  - 9.1.2.6 US
    - 9.1.2.6.1 Overview
    - 9.1.2.6.2 US Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.2.7 US Sleep Apnea Market, by Type
    - 9.1.2.7.1 US Sleep Apnea Market, by Diagnostic Devices
    - 9.1.2.7.2 US Sleep Apnea Market, by Therapeutic Devices
    - 9.1.2.7.2.1 US Sleep Apnea Market, by PAP
  - 9.1.2.8 US Sleep Apnea Market, by End User
  - 9.1.2.9 Canada
    - 9.1.2.9.1 Overview
    - 9.1.2.9.2 Canada Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.2.10 Canada Sleep Apnea Market, by Type
    - 9.1.2.10.1 Canada Sleep Apnea Market, by Diagnostic Devices
    - 9.1.2.10.2 Canada Sleep Apnea Market, by Therapeutic Devices
    - 9.1.2.10.2.1 Canada Sleep Apnea Market, by PAP
  - 9.1.2.11 Canada Sleep Apnea Market, by End User
  - 9.1.2.12 Mexico
    - 9.1.2.12.1 Overview
    - 9.1.2.12.2 Mexico Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.2.13 Mexico Sleep Apnea Market, by Type
    - 9.1.2.13.1 Mexico Sleep Apnea Market, by Diagnostic Devices
    - 9.1.2.13.2 Mexico Sleep Apnea Market, by Therapeutic Devices
    - 9.1.2.13.2.1 Mexico Sleep Apnea Market, by PAP
  - 9.1.2.14 Mexico Sleep Apnea Market, by End User
  - 9.1.2.15 Brazil
    - 9.1.2.15.1 Overview
    - 9.1.2.15.2 Brazil Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.2.16 Brazil Sleep Apnea Market, by Type
    - 9.1.2.16.1 Brazil Sleep Apnea Market, by Diagnostic Devices
    - 9.1.2.16.2 Brazil Sleep Apnea Market, by Therapeutic Devices
    - 9.1.2.16.2.1 Brazil Sleep Apnea Market, by PAP
  - 9.1.2.17 Brazil Sleep Apnea Market, by End User
  - 9.1.2.18 Argentina
    - 9.1.2.18.1 Overview
    - 9.1.2.18.2 Argentina Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.2.19 Argentina Sleep Apnea Market, by Type
    - 9.1.2.19.1 Argentina Sleep Apnea Market, by Diagnostic Devices
    - 9.1.2.19.2 Argentina Sleep Apnea Market, by Therapeutic Devices
    - 9.1.2.19.2.1 Argentina Sleep Apnea Market, by PAP
  - 9.1.2.20 Argentina Sleep Apnea Market, by End User
  - 9.1.2.21 Chile
    - 9.1.2.21.1 Overview
    - 9.1.2.21.2 Chile Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.2.22 Chile Sleep Apnea Market, by Type
    - 9.1.2.22.1 Chile Sleep Apnea Market, by Diagnostic Devices
    - 9.1.2.22.2 Chile Sleep Apnea Market, by Therapeutic Devices
    - 9.1.2.22.2.1 Chile Sleep Apnea Market, by PAP
  - 9.1.2.23 Chile Sleep Apnea Market, by End User
  - 9.1.2.24 Peru
    - 9.1.2.24.1 Overview
    - 9.1.2.24.2 Peru Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.2.25 Peru Sleep Apnea Market, by Type
    - 9.1.2.25.1 Peru Sleep Apnea Market, by Diagnostic Devices
    - 9.1.2.25.2 Peru Sleep Apnea Market, by Therapeutic Devices
    - 9.1.2.25.2.1 Peru Sleep Apnea Market, by PAP
  - 9.1.2.26 Peru Sleep Apnea Market, by End User
  - 9.1.2.27 Colombia
    - 9.1.2.27.1 Overview
    - 9.1.2.27.2 Colombia Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.2.28 Colombia Sleep Apnea Market, by Type
    - 9.1.2.28.1 Colombia Sleep Apnea Market, by Diagnostic Devices
    - 9.1.2.28.2 Colombia Sleep Apnea Market, by Therapeutic Devices
    - 9.1.2.28.2.1 Colombia Sleep Apnea Market, by PAP
  - 9.1.2.29 Colombia Sleep Apnea Market, by End User
  - 9.1.2.30 Rest of Americas
    - 9.1.2.30.1 Overview
    - 9.1.2.30.2 Rest of Americas Sleep Apnea Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.2.31 Rest of Americas Sleep Apnea Market, by Type
    - 9.1.2.31.1 Rest of Americas Sleep Apnea Market, by Diagnostic Devices
    - 9.1.2.31.2 Rest of Americas Sleep Apnea Market, by Therapeutic Devices
    - 9.1.2.31.2.1 Rest of Americas Sleep Apnea Market, by PAP
  - 9.1.2.32 Rest of Americas Sleep Apnea Market, by End User

10. Pre and Post COVID-19 Impact

10.1 Pre and Post COVID-19 Impact

11. Industry Landscape

11.1 Overview
11.2 Organic Developments
- 11.2.1 Overview
11.3 Inorganic Developments
- 11.3.1 Overview

12. Company Profiles

12.1 ResMed Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Nihon Kohden Corp
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Fisher & Paykel Healthcare Ltd
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Koninklijke Philips NV
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Cadwell Industries Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Natus Medical Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Compumedics Limited
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 LivaNova Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Invacare Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Braebon Medical Corporation
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
12.11 Financial Overview
- 12.11.1 SWOT Analysis
- 12.11.2 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms